
Cytora is a clinical-stage regenerative medicine company developing allogeneic cell therapies derived from human oral mucosa stem cells (hOMSCs) - a unique neural crest- derived population with regenerative, neuroprotective, and immunomodulatory properties. Its lead candidate, hOMSC200, has demonstrated statistically significant efficacy and a strong safety profile in a completed Phase 2a trial for wound management (diabetic...
Dr. Yona Geffen
CEO
Prof. Sandu Pitaru
Co-Founder & VP R&D
Jacob Zankel
Co-founder & COO